 RESEARCH TRIANGLE PARK, N.C., Dec. 05, 2022 GLOBE NEWSWIRE -- BioCryst Pharmaceuticals, Inc. Nasdaq: BCRX today announced that the company will present virtually at the JMP Securities Hematology Oncology Summit on Wednesday, December 7, 2022, at 11:40 a.m. ET. 